INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Observational study / 2023

Over 90,000 people in the US tested positive for alpha-gal-specific IgE antibodies between 2017 and 2022, mostly in southern, midwestern, and mid-Atlantic regions.

Researchers analyzed 357,119 alpha-gal-specific IgE tests from 295,400 persons in the United States from January 2017 to December 2022. Overall, 90,018 persons (30.5%) received a positive result, with annual positive individuals increasing from 13,371 in 2017 to 18,885 in 2021. Among 233,521 individuals with available geographic data, suspected cases predominantly occurred in counties within southern, midwestern, and mid-Atlantic regions.

Shows an association, not proof of cause and effect.

Study type
Retrospective laboratory surveillance study
Who was studied
295,400 persons with alpha-gal sIgE test results in the US (2017–2022)
What was measured
Alpha-gal-specific IgE positivity and geographic distribution of suspected cases

THE PAPER

Geographic Distribution of Suspected Alpha-gal Syndrome Cases - United States, January 2017-December 2022.

Thompson JM, Carpenter A, Kersh GJ, Wachs T, Commins SP, Salzer JS. MMWR Morb Mortal Wkly Rep, 2023.

PubMed 37498787 ↗DOI 10.1177/2150131917705714 ↗

Food safety & contaminantsOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.